Breast tissue characterization with photon-counting spectral CT imaging: A postmortem breast study

Radiology

Volumn 272, Issue 3, 2014, Pages 731-738

  Ding, Huanjun ^a   Klopfer, Michael J ^a   Ducote, Justin L ^a   Masaki, Fumitaro ^a   Molloi, Sabee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; BREAST; CADAVER; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; LIPIDS; MAMMOGRAPHY; PHOTONS; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; WATER;

EID: 84906859951     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132732     Document Type: Article

References (47)

1. Sala M, Comas M, Macià F, Martinez J, Casamitjana M, Castells X. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection. Radiology 2009;252(1):31-39.
2. Zare Z, Faghihi Langroudi T. Findings of breast sonography in patients with foal asymmetric breast density on mammography. Iran Red Crescent Med J 2011;13(6):404-406.
3. Shin HJ, Kim HH, Ahn JH, et al. Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol 2011;84(1003):612-620.
4. Houssami N, Miglioretti DL. Early detection of breast cancer the second time around: mammography in women with a personal history of breast cancer. Med J Aust 2011;194(9):439-440.
5. Feig S. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI. Obstet Gynecol Clin North Am 2011;38(1):179-196, ix.
6. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992;184(3):613-617.
7. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of inter-val- and screen-detected cancers. J Natl Cancer Inst 2000;92(13):1081-1087. (Pubitemid 30616482)
8. Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209(2):511-518. (Pubitemid 28503121)
9. Poplack SP, Carney PA, Weiss JE, Titus-Ernstoff L, Goodrich ME, Tosteson AN. Screening mammography: costs and use of screening-related services. Radiology 2005;234(1):79-85. (Pubitemid 39658372)
10. Woods RW, Sisney GS, Salkowski LR, Shinki K, Lin Y, Burnside ES. The mammographic density of a mass is a significant predictor of breast cancer. Radiology 2011;258(2):417-425.
11. Diekmann F, Freyer M, Diekmann S, et al. Evaluation of contrast-enhanced digital mammography. Eur J Radiol 2011;78(1):112-121.
12. Pinker K, Perry N, Milner S, Mokbel K, Duffy S. Accuracy of breast cancer detection with full-field digital mammography and integral computer-aided detection correlated with breast density as assessed by a new automated volumetric breast density measurement system. Breast Cancer Res 2010;12(Suppl 3):P4.
13. Pinker K, Perry N, Milner S, Mokbel K, Duffy S. Sensitivity of integral computeraided detection with full-field digital mammography for detection of breast cancer according to different histopathological tumor types and appearances. Breast Cancer Res 2010;12(Suppl 3):P13.
14. Chung SH, Cerussi AE, Klifa C, et al. In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy. Phys Med Biol 2008;53(23):6713-6727.
15. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006;11(4):044005.
16. Tromberg BJ, Cerussi A, Shah N, et al. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in premenopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005;7(6):279-285. (Pubitemid 41830168)
17. Haka AS, Shafer-Peltier KE, Fitzmaurice M, Crowe J, Dasari RR, Feld MS. Diagnosing breast cancer by using Raman spectroscopy. Proc Natl Acad Sci U S A 2005;102(35):12371-12376. (Pubitemid 41266366)
18. Olmstead E-G. Mammalian cell water: physiologic and clinical aspects. Philadelphia, Pa: Lea & Febiger, 1966; 185-195.
19. McIntyre GI. Increased cell hydration promotes both tumor growth and metastasis: a biochemical mechanism consistent with genetic signatures. Med Hypotheses 2007;69(5):1127-1130. (Pubitemid 47430205)
20. McIntyre GI. Cell hydration as the primary factor in carcinogenesis: A unifying concept. Med Hypotheses 2006;66(3):518-526. (Pubitemid 43060167)
21. Laidevant AD, Malkov S, Flowers CI, Kerlikowske K, Shepherd JA. Compositional breast imaging using a dual-energy mammography protocol. Med Phys 2010;37(1):164-174.
22. Ding H, Ducote JL, Molloi S. Breast composition measurement with a cadmium-zinc-telluride based spectral computed tomography system. Med Phys 2012;39(3):1289-1297.
23. Kalender WA, Beister M, Boone JM, Kolditz D, Vollmar SV, Weigel MC. High-resolution spiral CT of the breast at very low dose: concept and feasibility considerations. Eur Radiol 2012;22(1):1-8.
24. Shikhaliev PM, Fritz SG. Photon counting spectral CT versus conventional CT: comparative evaluation for breast imaging application. Phys Med Biol 2011;56(7):1905-1930.
25. Bornefalk H, Danielsson M. Photon-counting spectral computed tomography using silicon strip detectors: a feasibility study. Phys Med Biol 2010;55(7):1999-2022.
26. Kalluri KS, Mahd M, Glick SJ. Investigation of energy weighting using an energy discriminating photon counting detector for breast CT. Med Phys 2013;40(8):081923.
27. Barber WC, Nygard E, Iwanczyk JS, et al. Characterization of a novel photon counting detector for clinical CT: count rate, energy resolution, and noise performance. In: Samei E, Hsieh J, eds. Proceedings of SPIE: medical imaging 2009 - physics of medical imaging. Vol 7258. Bellingham, Wash: SPIE-The International Society for Optical Engineering, 2009; 725824.
28. Ding H, Ducote JL, Molloi S. Measurement of breast tissue composition with dual energy cone-beam computed tomography: a postmortem study. Med Phys 2013;40(6):061902.
29. Wilson JP, Mulligan K, Fan B, et al. Dualenergy X-ray absorptiometry-based body volume measurement for 4-compartment body composition. Am J Clin Nutr 2012;95(1):25-31.
30. Johnson T, Ding H, Le HQ, Ducote JL, Molloi S. Breast density quantification with cone-beam CT: a post-mortem study. Phys Med Biol 2013;58(23):8573-8591.
31. Boone JM. Normalized glandular dose (DgN) coefficients for arbitrary X-ray spectra in mammography: computer-fit values of Monte Carlo derived data. Med Phys 2002;29(5):869-875. (Pubitemid 34525916)
32. Le Huy Q, Ducote JL, Molloi S. Radiation dose reduction using a CdZnTe-based computed tomography system: comparison to flat-panel detectors. Med Phys 2010;37(3):1225-1236.
33. Xu C, Danielsson M, Bornefalk H. Evaluation of energy loss and charge sharing in cadmium telluride detectors for photoncounting computed tomography. IEEE Trans Nucl Sci 2011;58(3):614-625.
34. Wang AS, Harrison D, Lobastov V, Tkaczyk JE. Pulse pileup statistics for energy discriminating photon counting x-ray detectors. Med Phys 2011;38(7):4265-4275.
35. Strassburg M, Schroeter C, Hackenschmied P. CdTe/CZT under high flux irradiation. J Instrum 2011;6(1):C01055.
36. Taguchi K, Frey EC, Wang XL, Iwanczyk JS, Barber WC. An analytical model of the effects of pulse pileup on the energy spectrum recorded by energy resolved photon counting x-ray detectors. Med Phys 2010;37(8):3957-3969.
37. Ding H, Molloi S. Image-based spectral distortion correction for photon-counting x-ray detectors. Med Phys 2012;39(4):1864-1876.
38. United States Department of Agriculture, eds. Determination of fat CLG-FAT. Washington, DC: Food Safety and Inspection Service, Office of Public Health Science, 2009; 1-8.
39. Ducote JL, Klopfer MJ, Molloi S. Volumetric lean percentage measurement using dual energy mammography. Med Phys 2011;38(8):4498-4504.
40. Johns PC, Yaffe MJ. X-ray characterisation of normal and neoplastic breast tissues. Phys Med Biol 1987;32(6):675-695. (Pubitemid 17098978)
41. Tomal A, Mazarro I, Kakuno EM, Poletti ME. Experimental determination of linear attenuation coefficient of normal, benign and malignant breast tissues. Radiat Meas 2010;45(9):1055-1059.
42. al-Bahri JS, Spyrou NM. Photon linear attenuation coefficients and water content of normal and pathological breast tissues. Appl Radiat Isot 1996;47(8):777-784. (Pubitemid 26301056)
43. Chen RC, Longo R, Rigon L, et al. Measurement of the linear attenuation coefficients of breast tissues by synchrotron radiation computed tomography. Phys Med Biol 2010;55(17):4993-5005.
44. Ciatto S, Houssami N, Apruzzese A, et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast 2005;14(4):269-275. (Pubitemid 41110187)
45. Woodard HQ, White DR. The composition of body tissues. Br J Radiol 1986;59(708):1209-1218. (Pubitemid 17223252)
46. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006;6:135-143.
47. Yaffe MJ, Boone JM, Packard N, et al. The myth of the 50-50 breast. Med Phys 2009;36(12):5437-5443.